Nitrogen mustards

Jan 08, 2020

New Treatment Approved in Canada for Most Common Type of Leukemia

Jul 18, 2019

Moleculin Announces Annamycin in Acute Myeloid Leukemia in Poland Advances to 3rd Cohort

Oct 31, 2018

AbbVie Announces Positive Results from CLL14, a Phase 3 Trial Evaluating a Venetoclax Combination as First-Line Therapy with a Fixed Duration of Treatment in Patients with Chronic Lymphocytic Leukemia

Oct 17, 2018

AbbVie Announces Supplemental New Drug Application Accepted for Priority Review by U.S. FDA for IMBRUVICA® (ibrutinib) in Combination with Obinutuzumab (GAZYVA®) for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Jun 07, 2018

CytRx Corporation Highlights NantCell Inc's Aldoxorubicin Clinical Data Presented at the American Society of Clinical Oncology 2018 Annual Meeting

May 17, 2018

CytRx Corporation Highlights NantCell Inc's Aldoxorubicin Clinical Data to be Presented at the American Society of Clinical Oncology 2018 Annual Meeting

Dec 01, 2017

B-Cell Chronic Lymphocytic Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Sep 07, 2017

CASI Provides Pipeline Development Update